SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Fundamental exits stealth as $1.2 billion unicorn, armed with $255 million for tabular AI

Full list of Israeli high-tech funding rounds in 2026

IBM invests in Israeli startup Anima to bring “vibe coding” into the enterprise

“Israeli startups are extremely tethered to the US market, and we don’t see a way to build a big company from Israel without relying on the US market”

Buzz

Most popular

Daily

Weekly

1

Israel signs $130 million deal with Elbit to outfit next-generation helicopters

2

Ilya Sutskever’s Safe Superintelligence engineer walks away to fix what AI breaks

3

Israeli startup raises $6.2 million to turn social media video into intelligence

4

Fundamental exits stealth as $1.2 billion unicorn, armed with $255 million for tabular AI

5

Cyera employees to sell tens of millions in shares at $9 billion valuation

Blood Cancer

4 stories about Blood Cancer

אחות אחיות רפואה סיעוד

Novartis Invests $10 Million in Anti-Cancer Company Ayala Pharmaceuticals

24.12.18|Lilach Baumer

The investment is part of a licensing option agreement signed between the two companies

פרופסור זליג אשחר

Scientist’s Ex-Wife Joins Legal Melee Over Kite Pharma Windfall

16.01.18|Zohar Shahar Levy

Zelig Eshhar, the patent holder for Kite Pharma’s anti-cancer technology, is currently being sued by a former student for infringement of patent rights

המדען הראשי ב כלל ביוטכנולוגיה ד"ר ג'וליאן אדמס

Pharma Veteran Julian Adams takes Helm at Gamida Cell

21.11.17|Lilach Baumer

The Novartis-backed company is developing a universal bone marrow transplant solution for patients unable to find a donor

Kite Pharma’s Cancer Drug Gets Regulatory Nod

19.10.17|Lilach Baumer

The cancer-treatment company, bought by Gilead Science in August for $11.9 billion, will sell one treatment course of the drug for $373,000